Allergan Hits Alcon With Combigan Patents
Allergan Inc. continues to pounce on rival drugmakers' attempts to market generic versions of Combigan, most recently accusing Alcon Inc. of infringing three patents for the glaucoma treatment....To view the full article, register now.
Already a subscriber? Click here to view full article